Chongqing Pharmaceutical Haoen Pharmaceutical Co., Ltd.

Chongqing Pharmaceutical Haoen Pharmaceutical Co., Ltd. was established in 2009 and is a controlling subsidiary of Chongqing Pharmaceutical (Group) Joint-stock Co., Ltd. The company has long been engaged in the wholesale operation of chemical active pharmaceutical ingredients and their preparations, antibiotic active pharmaceutical ingredients and their preparations, biochemical drugs, biological products, protein assimilation preparations, peptide hormones, Chinese patent medicines, Chinese medicinal materials, Chinese herbal decoction pieces, medical toxic drugs (traditional Chinese medicine), and Class I, II, and III medical devices, food, and other dosage forms and specifications, as well as human stem cell technology consulting and application.
Since its establishment, the company has always adhered to law-abiding compliance and honest operation. In 2012, it was awarded the title of Honest Enterprise in the Construction of Drug Safety Integrity System by the Yuzhong Branch of the Municipal Food and Drug Administration, and has maintained it to this day. The company is a vice president unit of the Chongqing Medical Insurance Association and an executive director unit of the Chongqing Antituberculosis Association.
At present, the company's business has covered more than 400 major medical institutions, commercial and terminal customers in Chongqing's main urban area and various districts and counties, including 35 tertiary hospitals such as affiliated hospitals of Army Medical University, more than 40 district and county secondary hospitals, more than 20 private hospitals, more than 130 disease control systems, tuberculosis prevention and control institutes, and primary health care institutions, and more than 200 commercial customers and chain pharmacies.
The company has more than 500 upstream customers, including manufacturers and operating enterprises of drugs, devices, food, and medical aesthetics products. At present, it has cumulatively operated more than 6,000 product specifications. The company actively strives for the distribution rights of drugs under national volume-based procurement and cooperates with upstream manufacturers in drug distribution. The company has established good strategic partnerships with well-known domestic pharmaceutical production and operation enterprises such as Dräger Medical Equipment of Germany, the Traditional Chinese Medicine Business Department of Sinopharm Group, Jiangsu Fosun, General Electric Pharmaceuticals (GE), and Yunnan Biovalley, and has the agency rights for some products in the Chongqing region.
The company is the general agent in Chongqing for artemisinin, an original new drug recognized worldwide and awarded the Nobel Prize in Physiology or Medicine; the company is the general agent in Chongqing for Dengzhan Shengmai Capsules, a basic drug with Grade A clinical trial evidence in evidence-based medicine for secondary prevention of stroke. The company is the first-level agent in Chongqing for many domestic manufacturers of tuberculosis prevention and treatment drugs, and can ensure the supply of commonly used tuberculosis drugs to medical institutions in the city; the company is the distributor that has been shortlisted in the bidding and procurement of the Chongqing Tuberculosis Prevention and Control Institute for three consecutive sessions, and is the distributor of free tuberculosis drugs in Chongqing. The company is the winning bidder and distributor of free antiparasitic drugs in Chongqing; the company has entered the IVD market sales field and currently reserves and distributes national centralized procurement nucleic acid testing reagents and other epidemic prevention materials for governments and hospitals in multiple regions such as Yuzhong District, Banan District, Nanchuan District, and High-tech Zone, fully ensuring the distribution of emergency medical materials.
The company has a professional staff team full of work passion and competitive awareness, and a leadership team with rich management experience, strictly following modern enterprise management norms in business activities. Employees with graduate, university, and college education or above account for more than 95%, including 3 licensed pharmacists and 2 inspectors, and personnel with intermediate and senior technical titles account for more than 30%.
The company conducts operations and management in strict accordance with GSP requirements, and the company's logistics distribution is uniformly undertaken by Chongqing Pharmaceutical Heping Logistics Co., Ltd. "Heping Logistics" is an advanced pharmaceutical logistics distribution center in Southwest China and a reserve unit for COVID-19 anti-epidemic materials of the Chongqing Municipal Government. It adopts a modern logistics distribution model and has established a complete quality supervision and tracking assurance system to ensure safe, timely, and efficient service to customers.
The company adheres to the purpose of "Hao Li Medicine, Benefiting the People," strictly controls operational quality, and does a good job in commercial distribution for governments at all levels and medical institutions. With the strong support of customers, the company unites its efforts, overcomes difficulties, forges strengths, and achieves high-quality development!